After facing a delayed decision deadline and a clinical hold, Regenxbio’s Hunter syndrome gene therapy has been rejected by ...

A new study from scientists at Cincinnati Children's suggests there may be a way to further protect transplanted hearts from rejection by preparing the donor organ and the recipient with an ...

Shares of Biogen Inc. were headed higher Wednesday, to bounce off an 11-year closing low, after the biotechnology company received positive news from regulators about its treatment for ...

A new study from scientists at Cincinnati Children's suggests there may be a way to further protect transplanted hearts from rejection by preparing the donor organ and the recipient with an ...

Once a transplant patient gets past the first week to three months with their new organ, the risk of rejection drops substantially—at least for the first year. But over time, the immunosuppressants ...

Investigational methods to predict transplant rejection are employing donor-derived cell-free DNA or transplant recipients’ immune cells. Several teams of investigators are developing noninvasive ...

A 5-year-old boy who stole hearts when he learned he was getting a long-awaited heart transplant is now being treated for acute rejection. The family received more bad news recently when they learned ...

Global Phase 3 TRANSCEND study will evaluate the efficacy and safety of felzartamab, as compared to placebo, in adults with late AMR AMR is a leading cause of kidney transplant loss, with ...

Lykos Therapeutics announced it would cut 75% of its staff as part of a reorganization on Thursday afternoon. This announcement came less than one week after the Food and Drug Administration rejected ...